However, the complexity of the tumour microenvironment in HCC, including the presence of hepatitis and cirrhosis, as well as the classification of PD-L1, might undermine the reliability of PD-L1 as a predictor for the effectiveness of ICIs (49). The gene discussed is CD274; the disease is Cirrhosis.